Cite

HARVARD Citation

    Loi, G. et al. (n.d.). 3 Evaluation of HO-1 involvement in melanoma resistance to BRAF inhibitor vemurafenib. Postgraduate medical journal. p. A6. [Online]. 
  
Back to record